Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Boeing gains amid news about potential huge 737 MAX order from China 📈
Wall Street tries to stop the deeper decline 🗽Marvell Technology jumps 10%
RyanAir shares under pressure amid Middle East conflict 📉
Stock of the Week: Broadcom Driven by AI Sets Records